<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Bridge Biotherapeutics Launches a Research Collaboration with Emory University School of Medicine to Explore Combination Therapy of BBT-877 for KRAS/P53 Mutant NSCLC Patients Resistant to Anti-PD-1 Blockade	</title>
	<atom:link href="https://9krapalm.com/bridge-biotherapeutics-launches-a-research-collaboration-with-emory-university-school-of-medicine-to-explore-combination-therapy-of-bbt-877-for-kras-p53-mutant-nsclc-patients-resistant-to-anti-pd-1-bl/feed/" rel="self" type="application/rss+xml" />
	<link>https://9krapalm.com/bridge-biotherapeutics-launches-a-research-collaboration-with-emory-university-school-of-medicine-to-explore-combination-therapy-of-bbt-877-for-kras-p53-mutant-nsclc-patients-resistant-to-anti-pd-1-bl/</link>
	<description>เสิร์ฟข่าวไอที อัปเดตเทคโนโลยีสไตล์ @krapalm</description>
	<lastBuildDate>Thu, 28 Mar 2024 22:49:33 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.3</generator>
</channel>
</rss>
